News & Events

Young Investigator Spotlight: Dörte Schulte

Young Investigator Spotlight: Dörte Schulte

While the Gordon Research Conference was about a month ago now, we are still hearing from some of the young researchers who had received LE&RN grants in order to attend the Conference. Just last week, we heard from Dörte Schulte who is a Postdoctoral fellow at the Hubrecht Institute for Developmental Biology and Stem Cell Research in the lab of Prof. Stefan Schulte-Merker, Utrecht, The Netherlands.

"I had a great experience at the conference," Dr. Schulte wrote. "The talks and posters were very exciting and presented a broad spectrum of topics about understanding principles in lymphatic mechanisms and disease. I was delighted to be able to present my work in a poster as well as in a talk, which led to stimulating discussions with other members of the lymphatic community. It was great to make contact with key figures in the field, which improves networking and collaborations for all of us. It was also a great setting to meet other scientists who are in similiar career states. We were able to talk about post-doc experiences and about research interests.

"In my graduate studies I have been working on vascular endothelial cells in the context of leukocyte extravasation. I continue to be interested in vascular research and especially in the emerging field of lymphangiogenesis. Thus, I started a postdoc in Stefan Schulte-Merker’s group at the Hubrecht Institute in Utrecht which in addition to continuing my work with mice, this gave me the chance to build expertise in working with a model organism that I have not worked with before, the zebrafish. Lymphangiogenesis is a very exciting field of science. There are many open research questions that need to be answered to understand the many different facets of lymphatic research, molecular mechanisms of lymphatic development, and the lymphatics in inflammation or cancer. In the future, I would like to establish myself as an independent scientist and start my own research group."

We thank Dr. Schulte for getting in touch, and we hope that she will keep us posted on her exciting research.